DeepWell will publish games with therapeutic value
GamesBeat Summit 2022 returns with its largest event for leaders in gaming on April 26-28th. Reserve your spot here!
DeepWell Digital Therapeutics (DTx) plans to develop and publish games that have therapeutic value and can treat a variety of health conditions.
The Seattle company was founded by medical device expert Ryan Douglas and Devolver Digital cofounder Mike Wilson, who has a decades-long career in games. Devolver went public in November 2021 with a valuation of $950 million, and that enabled Wilson to finance his new dream.
DeepWell hopes to combine entertaining gameplay and medical benefits at the same time, said Wilson, in an interview with GamesBeat. DeepWell believes that video games have the potential to change lives and these games can be available worldwide to anyone with an internet connection and a desire to better themselves through the power of play.
Wilson has formed a team of game industry experts and medical luminaries with Douglas, who is the former CEO of the medical device company Nextern. DeepWell will make its own games, working with independent creators worldwide to publish new titles spanning every platform and genre.
GamesBeat Summit 2022
And it will open the company’s research-driven technologies to assist developers in designing and repurposing games to magnify their innate therapeutic value. DeepWell is already hard at work on a slate of DTx-enabled games that will support the company’s patented technical processes and systems.
The company will offer support for other publishers or even self-publishing game makers to ensure their games are more beneficial for players. On top of that, Wilson said the company will identify games that already exist and are beneficial players — and then it will
Read more on venturebeat.com
